US 11286265
Macrocyclic compounds for treating disease
granted A61PA61P35/00
Quick answer
US patent 11286265 (Macrocyclic compounds for treating disease) held by TURNING POINT THERAPEUTICS, INC. expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TURNING POINT THERAPEUTICS, INC.
- Grant date
- Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P35/00